Thomas Kicmal

Thomas Kicmal

Auto-generated profile, based on publicly available information

Thomas Kicmal

Department of Microbiology and Immunology, Loyola University Chicago, Maywood, IL, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2022 in Science Advances
Verified
Journal Article
Open access
TMTara C. Marcink
Tara C. Marcink
TKThomas Kicmal
Thomas Kicmal
EAEmily Armbruster
Emily Armbruster
ZZZhening Zhang
Zhening Zhang
GZGillian Zipursky
Gillian Zipursky
AMAnne Moscona
Anne Moscona
SARS-CoV-2 cell entry is completed after viral spike (S) protein–mediated membrane fusion between viral and host cell membranes. Stable prefusion and postfusion S structures have been resolved by cryo–electron microscopy and cryo–electron tomography, but the refolding intermediates on the fusion pathway are transient and have not been examined. We used an antiviral lipopeptide entry inhibitor to arrest S protein refolding and thereby capture intermediates as S proteins interact with hACE2 and fusion-activating proteases on cell-derived target membranes. Cryo–electron tomography imaged both extended and partially folded intermediate states of S2, as well as a novel late-stage conformation on the pathway to membrane fusion. The intermediates now identified in this dynamic S protein–directed fusion provide mechanistic insights that may guide the design of CoV entry inhibitors.